Literature DB >> 27602149

Chemotherapy for a ventilator-supported patient with small cell lung cancer: A case report.

Run Xiang1, Tianpeng Xie1, Qiang Li1.   

Abstract

Small cell lung cancer (SCLC) is common in thoracic neoplasms, with a high degree of malignancy and rapid tumor progression. SCLC is often diagnosed with widespread metastases at the time of the initial diagnosis. A small proportion of late-stage SCLC patients are in a poor physical condition and exhibit disqualifying chemoradiotherapy indications. The present study reports the case of a patient who presented with lumbago and backache. Following physical examination, computed tomography, bronchoscopy and biopsy, the patient was diagnosed with SCLC with an Eastern Cooperative Oncology Group score of <2. One cycle of chemotherapy was administered whilst ventilator support was provided, and the patient's condition eventually improved. However, the patient finally succumbed to respiratory failure at 10 months post-diagnosis.

Entities:  

Keywords:  chemotherapy; small cell lung cancer; ventilator

Year:  2016        PMID: 27602149      PMCID: PMC4998516          DOI: 10.3892/ol.2016.4861

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  6 in total

1.  Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?

Authors:  E Verger; M Salamero; C Conill
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 2.  Small-cell lung cancer.

Authors:  Jan P van Meerbeeck; Dean A Fennell; Dirk K M De Ruysscher
Journal:  Lancet       Date:  2011-05-10       Impact factor: 79.321

3.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

4.  Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

Authors:  J von Pawel; J H Schiller; F A Shepherd; S Z Fields; J P Kleisbauer; N G Chrysson; D J Stewart; P I Clark; M C Palmer; A Depierre; J Carmichael; J B Krebs; G Ross; S R Lane; R Gralla
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

5.  Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

Authors:  G Buccheri; D Ferrigno; M Tamburini
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

6.  Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  James R Jett; Steven E Schild; Kenneth A Kesler; Gregory P Kalemkerian
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.